Description: Pulse Biosciences, Inc., a development stage medical device company, focuses on developing medical technologies based on sub-microsecond pulsed electric field technology to detect and treat skin cancer and enhance wound healing. The company was formerly known as Electroblate, Inc. and changed its name to Pulse Biosciences, Inc. in December 2015. Pulse Biosciences, Inc. was founded in 2014 and is based in Burlingame, California.
Home Page: www.pulsebiosciences.com
PLSE Technical Analysis
3957 Point Eden Way
Hayward,
CA
94545
United States
Phone:
510 906 4600
Officers
| Name | Title |
|---|---|
| Mr. Robert W. Duggan | Exec. Chairman |
| Mr. Darrin R. Uecker | CTO & Director |
| Mr. Mitchell E. Levinson | Chief Strategy Officer & Director |
| Mr. Kevin Danahy | Pres & CEO |
| Dr. Richard Nuccitelli Ph.D. | Chief Science Officer |
| Mr. Kenneth B. Stratton Esq., J.D. | Gen. Counsel & Corp. Sec. |
| Dr. Holly Hartman J.D., Ph.D. | VP of Bus. Devel. & Corp. Strategy |
| Ms. Patty Perla | VP of HR |
| Mr. David Danitz | Sr. VP of Engineering |
Exchange: NASDAQ
Country: US : United States of America
Currency: US Dollar ($)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Health Care Equipment & Services |
| GIC Industry: | Health Care Equipment & Supplies |
| GIC Sub-Industry: | Health Care Equipment |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 15.2185 |
| Price-to-Sales TTM: | 60.4089 |
| IPO Date: | 2016-05-18 |
| Fiscal Year End: | December |
| Full Time Employees: | 142 |